Patent Assignment
Reel/Frame 037443/0316
Merger
Recorded: 2016-01-08
Pages: 14
Assignors
ANDAMAN THERAPEUTICS, INC.
Executed: 2014-01-14
ALPINE BIOSCIENCES, LLC
Executed: 2014-01-14
Assignee
ALPINE BIOSCIENCES, INC.
600 STEWART STREET, SUITE 1503, SEATTLE, WASHINGTON, 98101
Covered Property
(1)
Dibenzo[B,F][1,4]Oxazapine Compounds
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 9, 2008
From: BECKER, CYRUS; RUBENS, COURTNEY; ADAMS, JASON; PALME, MONICA
To: ARYX THERAPEUTICS, INC.
Reel/Frame 020927/0850 →
Security Agreement
Oct 18, 2010
From: ARYX THERAPEUTICS, INC.
To: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
Reel/Frame 025150/0379 →
Assignment of Assignor's Interest
May 16, 2012
From: ARYX THERAPEUTICS, INC.
To: ANDAMAN THERAPEUTICS, INC.
Reel/Frame 028221/0270 →
Merger
Jan 8, 2016
From: AB ACQUISITION; ALPINE BIOSCIENCES, INC.
To: ALPINE BIOSCIENCES, INC.
Reel/Frame 037464/0155 →
Change of Name
Jan 11, 2016
From: ALPINE BIOSCIENCES, INC.
To: PROTOCELL THERAPEUTICS INC.
Reel/Frame 037471/0445 →